The 2018 ANZGOG Annual Scientific Meeting will be held at the Hilton Brisbane on 4 to 7 April 2018. We are pleased to announce our two distinguished international speakers:

- Dr Martee Hensley (Medical Oncologist, New York, USA)
- Dr Michael Milosevic (Radiation Oncologist, Toronto, Canada)
- Dr Jessica McAlpine (Gynaecologic Oncologist, Vancouver, Canada)

Will be providing keynote addresses.  We also have outstanding speakers from Australia and New Zealand.

Inspired by the theme 'Challenges in precision gynaecological cancer care in the molecular era', the ASM will host our fourth Pure Science Symposium on Wednesday afternoon.  Other sessions at the ASM include:

- Immunotherapy
- Rare Cancers
- Trial Updates
- Quality & Survivorship
- Trial Concepts & Updates
- Controversies in Gynaecological Cancer
- Molecular Tumour Board

A new session on Translational ANZGOG & Pathology has been added to the program. ANZGOG continues its popular series of speciality workshops with Concept Development, Radiation Oncology, and education workshops for Study Coordinators, Consumers and Gynaecological Cancer Nurses. We would like to thank members of the ANZGOG Scientific Meeting Program Committee for helping to organise the Annual Scientific Meeting 2018.


Dr Paul Cohen                                                         Associate Professor Alison Brand
ASM Committee Chair                                          ANZGOG Chair

Dr Paul Cohen (Convenor)

 Associate Professor Alison Brand

Dr Andy Garrett

Dr Adam Pendlebury

Ms Catherine Adams

Dr Alison Davis

 Dr Jim Coward

Dr Cath Shannon

Dr Mahesh Iddawela

Ms Vanessa Taylor

Dr Elaine Sanij

 

Dr Peter Sykes (Past Convenor)

Dr Raj Kader Ali Mohan

Dr Sumitra Ananda

Dr Ganessan Kichenadasse

Dr Jeffrey Goh

Dr Pearly Khaw

Dr Viet Do

Dr Nicole McCarthy

Dr Pamela Pollock

Dr Lyndal Anderson

Alison Evans, ANZGOG CEO

Kate Murphy, Conference Organiser

Martee Hensley, Medical Oncologist, New York, USA

Martee L. Hensley, M.D., M.Sc. is a medical oncologist specializing in the treatment of gynecologic cancers. Her clinical research and academic oncology practice are dedicated to improving the lives of women with gynecologic sarcomas. Dr. Hensley has served as principal investigator for national and international studies in gynecologic sarcomas. She serves as co-Chair of the National Cancer Institute’s Uterine Task Force.  She is the U.S. Chair for the International Rare Cancer Initiative-gynecologic sarcoma group.  She is Editor-in-Chief for the American Society of Clinical Oncology-Self Evaluation Program (ASCO-SEP).  She received her MD degree in 1989 from Duke University School of Medicine, completed her internship and residency in internal medicine, and her fellowship in hematology and medical oncology, at The New York Presbyterian Hospital-Cornell.  She received her M.Sc. from Harvard School of Public Health in 1998. She joined the faculty of Memorial Sloan Kettering Cancer Center in 1998, where she is currently Attending Physician, Gynecologic Medical Oncology service, and Professor of Medicine, Weill Cornell Medical College.  Since January 2016, she has served as Chair of the Hospital Quality Assessment Committee.

Michael Milosevic, Radiation Oncologist, Toronto, Canada

Dr. Milosevic is a radiation oncologist in the Radiation Medicine Program, Princess Margaret Cancer Centre and University Health Network, Toronto, Canada. He is a Professor  and  the  Vice-­‐Chair  of  Research  in  the  Department  of  Radiation  Oncology  at the  University  of  Toronto,  a  past-­‐President  of  the  Canadian  Association  of  Radiation Oncology (CARO) and the Chair of the Canadian Partnership for Quality in Radiotherapy (CPQR). Dr. Milosevic’s clinical practice is focused on the management of women with gynecological cancers. His research revolves around the influence of hypoxia and other biological determinants of gynecological cancer behavior and radiation treatment response, molecular therapeutics to overcome radiation treatment resistance, and the application of adaptive, MR-­‐guided external beam radiotherapy and brachytherapy.

Jessica McAlpine, Gynaecologic Oncologist, Vancouver, Canada

Dr. Jessica McAlpine is an Associate Professor in the Department of Gynecology, Division of Gynecologic Oncology at the University of British Columbia and BC Cancer Agency, Vancouver, Canada. She did her medical training in the US; medical school at Johns Hopkins, residency at Stanford in Obstetrics and Gynecology, and Fellowship at Yale in Gynecologic Oncology.  She currently splits her time equally between surgical/clinical work and translational research.  She is part of the OVCARE research team (British Columbia’s Ovarian Cancer Research group), Director of the OVCARE Tissue Bank and recipient of a CIHR New Investigator Award (2013-2018) and BC Cancer Foundations Clinician Scientist Award (2016-2021). Her research focuses on molecular/genomic characterization of ovarian, endometrial and vulvar cancers as well as ovarian cancer prevention.

CALL FOR ABSTRACTS GUIDELINE

 CLICK HERE TO SUBMIT ABSTRACT

 

Deadline for Abstract Submission 11.59pm Wednesday 14th February 2018
Oral Presentation at the ASM 4th - 7th April
Poster Presentation at the ASM 4th - 5th April

Any issues in submitting an abstract or concept please contact ANZGOG Conference Secretariat on 07 3368 2422 or via email at anzgog@yrd.com.au

CALL FOR CONCEPT SUBMISSION GUIDELINES

CONCEPT SUBMISSION

Deadline for Concept Submission 11.59pm Monday 19th February 2018
Presentation to the relevant Tumour Type Working Group Wednesday 4th April
Presentation of Concept at ASM Friday 6th April
Concept Development Workshop Friday 6th April

 

Select a registration type

Full Registration

REGISTER NOW

Full registration includes tickets to all social functions.  Early Bird registration have now closed
Please read our cancellation policy prior to registering.

Regular
Member Medical $1180
Member Medical - Trainee, PHD, Registrar, Fellow $650
Member - Nurse, Data Manager, Study Coordinator, Consumer $350
Member - Non-Medical Cancer Organisation, Laboratory Researcher $650
Non-Member Medical $1380
Non-Member Non Medical/Nurse/Trainee $950

Pure Science Symposium Only

Wednesday 4th April
1.30PM - 5.00PM

Please note this registration is if you are only able to attend the Pure Science Symposium only.  If you are registering for the full conference attendance included.

Regular
Member Medical $295
Member Medical - Trainee, PHD, Registrar, Fellow $295
Member - Non-Medical Cancer Organisation, Laboratory Researcher $295
Non-Member Medical $395
Non-Member Non Medical/Nurse/Trainee $395

Day Registrations

Thursday, Friday and Saturday

Regular
Member Medical $495
Member Medical - Trainee, PHD, Registrar, Fellow $295
Member - Non-Medical Cancer Organisation, Laboratory Researcher $295
Non-Member Medical $595
Non-Member Non Medical/Nurse/Trainee $595

ANZGOG is pleased to advise that the 2018 ANZGOG ASM has been approved as a RANZCOG Approved O&G Meeting and eligible Fellows of the College can claim points for attendance as follows:

CPD Online Program (Clinical Expertise Domain):

Full attendance (conference only) 21.5 PD Points
Attendance: 4 April 3 PD points
Attendance: 5 April 7.5 PD points
Attendance: 6 April 7 PD Points
Attendance: 7 April 4 PD Points
Attendance: Breakfast Sessions (Fri/Sat) 1.5 PD Points per session

“Challenging the status-quo of women’s cancers”

Saturday 7 April, 12:30 – 4:30pm at the Hilton, Brisbane.

 

Speakers:

Associate Professor Clare Scott
Dr Paul Cohen
Dr Helen Gooden
and more!

Summary:

Public guests are invited to hear from Australia’s leading clinician researchers about the latest studies, discoveries, and programs that are challenging the status-quo of three women’s cancers: ovarian, cervical and endometrial.

Hear also from some of the women whose lives have been affected by these cancers and what they’re doing now.

From world first clinical studies to consumer-led education and breaking the taboo on women’s intimate parts, it IS possible to improve outcomes and quality of life for women living with gynaecological cancer.

Brisbane Hilton

Located in the heart of Brisbane, in the Queen Street Mall, the Brisbane Hilton will host Australia New Zealand Gynaecological Oncology Group Annual Scientific Meeting 2018.

Walking distance from 5-star restaurants and many of Brisbane's main attractions we trust that your experience at the Brisbane Hilton will be great.  With the Commonwealth Games starting just after the meeting why not extend your stay, and bring family with you.


Hilton Brisbane

Hilton Guest Room

$200 / night

Oaks Charlotte Towers

One Bedroom Apartment

$184 / night

Two Bedroom Apartment

$289 / night

The 2018 Sponsorship Prospectus is now available.  Please contact the Conference Secretariat on the link below for a copy.

Sponsorship Prospectus

PLATINUM AND PURE SCIENCE SYMPOSIUM SPONSOR

 

 

GOLD SPONSOR

 

CONFERENCE APP, WORKSHOP AND 
EXHIBITOR SPONSOR

SCIENTIFIC SESSION SPONSOR

EXHIBITORS

 

 

 

Follow us #ANZGOG2018